Edition:
India

GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

12.55USD
22 Nov 2017
Change (% chg)

$0.05 (+0.40%)
Prev Close
$12.50
Open
$12.55
Day's High
$12.95
Day's Low
$12.39
Volume
74,990
Avg. Vol
113,637
52-wk High
$16.94
52-wk Low
$3.83

Chart for

About

GlycoMimetics, Inc. is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and development of glycomimetic compounds segment. The Company is developing its lead drug candidate, GMI-1070 (Rivipansel), for the treatment... (more)

Overall

Beta: 3.18
Market Cap(Mil.): $426.05
Shares Outstanding(Mil.): 32.72
Dividend: --
Yield (%): --

Financials

BRIEF-GlycoMimetics qtrly loss per share $‍0.24

* Glycomimetics reports program updates and third quarter 2017 results

08 Nov 2017

BRIEF-GlycoMimetics says files for mixed shelf of upto $250 mln

* GlycoMimetics Inc says files for mixed shelf of upto $250.0 million - SEC filing‍​ Source text: (http://bit.ly/2xOoKE6) Further company coverage:

29 Sep 2017

BRIEF-GlycoMimetics Inc says to receive European patent for GMI-1271

* GlycomiMetics Inc says to receive European patent for GMI-1271; will have claims directed at GMI-1271 extending at least until 2032 Source text for Eikon: Further company coverage:

06 Jul 2017

BRIEF-Glycomimetics' GMI-1271 receives EU orphan drug designation

* Glycomimetics' GMI-1271 receives EU orphan drug designation for acute myeloid leukemia Source text for Eikon: Further company coverage:

25 May 2017

BRIEF-Glycomimetics announces pricing of public offering of common stock

* Glycomimetics announces pricing of public offering of common stock

24 May 2017

BRIEF-Glycomimetics Inc terminates sales agreement with Cowen and Company

* Glycomimetics Inc - co terminated its sales agreement, dated March 1, 2016, with Cowen and Company Source text for Eikon: (http://bit.ly/2qaOyrv) Further company coverage:

24 May 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $137.29 -1.05
Novartis AG (NOVN.S) CHF83.60 +0.30
Pfizer Inc. (PFE.N) $35.43 -0.11
Merck & Co., Inc. (MRK.N) $54.37 +0.10
Roche Holding Ltd. (ROG.S) CHF246.90 +0.10
Roche Holding Ltd. (RO.S) CHF248.20 -0.20
Bayer AG (BAYGn.DE) €108.50 0.00
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates